These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35461262)

  • 61. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study.
    Stamm TJ; Lewitzka U; Sauer C; Pilhatsch M; Smolka MN; Koeberle U; Adli M; Ricken R; Scherk H; Frye MA; Juckel G; Assion HJ; Gitlin M; Whybrow PC; Bauer M
    J Clin Psychiatry; 2014 Feb; 75(2):162-8. PubMed ID: 24345793
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
    Amsterdam JD; Shults J
    Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
    Machado-Vieira R; Soares JC; Lara DR; Luckenbaugh DA; Busnello JV; Marca G; Cunha A; Souza DO; Zarate CA; Kapczinski F
    J Clin Psychiatry; 2008 Aug; 69(8):1237-45. PubMed ID: 18681754
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
    Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
    J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ghaemi SN; Whitham EA; Vohringer PA; Barroilhet SA; Amerio A; Sverdlov O; Patkar AA
    J Clin Psychiatry; 2021 Jan; 82(1):. PubMed ID: 33434956
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of systemic antidepressant treatments in early stage on neurocognitive function of euthymic bipolar patients initiated with a depressive onset: An observational, cross-sectional, single-blind study protocol.
    Yang H; Liu Y; Yang C; Lin X
    Brain Behav; 2021 Oct; 11(10):e2360. PubMed ID: 34520638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions.
    Drevets WC; Bhattacharya A; Furey ML
    Adv Pharmacol; 2020; 89():357-386. PubMed ID: 32616213
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
    Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.
    Vieta E; Montgomery S; Sulaiman AH; Cordoba R; Huberlant B; Martinez L; Schreiner A
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):825-35. PubMed ID: 22503488
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
    Saricicek A; Maloney K; Muralidharan A; Ruf B; Blumberg HP; Sanacora G; Lorberg B; Pittman B; Bhagwagar Z
    J Clin Psychiatry; 2011 Jun; 72(6):744-50. PubMed ID: 21034692
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial.
    El-Mallakh RS; Vöhringer PA; Ostacher MM; Baldassano CF; Holtzman NS; Whitham EA; Thommi SB; Goodwin FK; Ghaemi SN
    J Affect Disord; 2015 Sep; 184():318-21. PubMed ID: 26142612
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [TBL] [Abstract][Full Text] [Related]  

  • 77. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
    Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
    Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression.
    Park LT; Lener MS; Hopkins M; Iadorola N; Machado-Vieira R; Ballard E; Nugent A; Zarate CA
    J Clin Psychopharmacol; 2017 Jun; 37(3):355-358. PubMed ID: 28338546
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
    Aftab A; Kemp DE; Ganocy SJ; Schinagle M; Conroy C; Brownrigg B; D'Arcangelo N; Goto T; Woods N; Serrano MB; Han H; Calabrese JR; Gao K
    J Affect Disord; 2019 Feb; 245():957-964. PubMed ID: 30699881
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones--the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial.
    Faurholt-Jepsen M; Vinberg M; Frost M; Christensen EM; Bardram J; Kessing LV
    BMC Psychiatry; 2014 Nov; 14():309. PubMed ID: 25420431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.